These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Segnan N; Senore C; Giordano L; Ponti A; Ronco G Tumori; 1998; 84(3):348-53. PubMed ID: 9678615 [TBL] [Abstract][Full Text] [Related]
5. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Baron RC; Melillo S; Rimer BK; Coates RJ; Kerner J; Habarta N; Chattopadhyay S; Sabatino SA; Elder R; Leeks KJ; Am J Prev Med; 2010 Jan; 38(1):110-7. PubMed ID: 20117566 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Sabatino SA; Lawrence B; Elder R; Mercer SL; Wilson KM; DeVinney B; Melillo S; Carvalho M; Taplin S; Bastani R; Rimer BK; Vernon SW; Melvin CL; Taylor V; Fernandez M; Glanz K; Am J Prev Med; 2012 Jul; 43(1):97-118. PubMed ID: 22704754 [TBL] [Abstract][Full Text] [Related]
7. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women. Charkhchi P; Schabath MB; Carlos RC J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405 [No Abstract] [Full Text] [Related]
8. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands. Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478 [TBL] [Abstract][Full Text] [Related]
9. Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study. Njor SH; Søborg B; Tranberg M; Rebolj M Prev Med; 2023 Feb; 167():107405. PubMed ID: 36581010 [TBL] [Abstract][Full Text] [Related]
10. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys. Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of special events to promote breast, cervical and colorectal cancer screening in the United States. Escoffery C; Rodgers KC; Kegler MC; Haardörfer R; Howard DH; Liang S; Pinsker E; Roland KB; Allen JD; Ory MG; Bastani R; Fernandez ME; Risendal BC; Byrd TL; Coronado GD BMC Public Health; 2014 Mar; 14():274. PubMed ID: 24661503 [TBL] [Abstract][Full Text] [Related]
12. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes. Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991 [TBL] [Abstract][Full Text] [Related]
14. Increasing breast, cervical, and colorectal cancer screening among rural women: Baseline characteristics of a randomized control trial. Biederman E; Baltic R; Katz ML; Rawl S; Vachon E; Monahan PO; Stump TE; Kettler C; Carter L; Young G; Xu W; Paskett ED; Champion V Contemp Clin Trials; 2022 Dec; 123():106986. PubMed ID: 36328234 [TBL] [Abstract][Full Text] [Related]
15. The education gradient in cancer screening participation: a consistent phenomenon across Europe? Willems B; Bracke P Int J Public Health; 2018 Jan; 63(1):93-103. PubMed ID: 29063122 [TBL] [Abstract][Full Text] [Related]
16. "It's cancer screening after all". Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening. Kirkegaard P; Larsen MB; Andersen B J Med Screen; 2023 Jun; 30(2):74-80. PubMed ID: 36541340 [TBL] [Abstract][Full Text] [Related]
17. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. Dietrich AJ; Tobin JN; Cassells A; Robinson CM; Reh M; Romero KA; Flood AB; Beach ML Ann Fam Med; 2007; 5(4):320-7. PubMed ID: 17664498 [TBL] [Abstract][Full Text] [Related]
18. Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention. Lönnberg S; Andreassen T; Engesæter B; Lilleng R; Kleven C; Skare A; Johansson K; Fredheim CS; Tropé A BMJ Open; 2016 Nov; 6(11):e013728. PubMed ID: 28186949 [TBL] [Abstract][Full Text] [Related]
19. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial. Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602 [TBL] [Abstract][Full Text] [Related]
20. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Eaker S; Adami HO; Granath F; Wilander E; Sparén P Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):346-54. PubMed ID: 15006907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]